Answers are grounded in this paper and cite their sources.
Hepatitis E virus (HEV) is one of the most common causes of acute viral hepatitis in developing countries with poor sanitation and hygiene. HEV is a non -enveloped RNA virus and its genome is formed by a non -segmented positive sense RNA chain. The virus is classified into four genotypes (1-4) with one serotype. Genotype I is the predominant strain in India. HEV infection is an underdiagnosed disease due to wide use of serological assay with low sensitivity. HEV infection outbreaks frequently occur due to fecal -oral transmission, usually through contamination of drinking water. Chronic infections are rare, except in organ transplant recipients, patients with hematological malignancy requiring chemotherapy, and individuals with HIV. Extrahepatic manifestations include a number of neurological syndromes and renal injury. Treatment is required in chronic infections by reducing immunosuppression in transplant patients and/or the use of antiviral therapy. A subunit vaccine has been shown to be effective in preventing the clinical disease, but it is not yet commercially available.
No takes yet. Share an insight, caveat, or question.
Neel et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: